RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 146 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,528 | +4.5% | 36,801 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $269,428 | +155.8% | 36,068 | +128.4% | 0.00% | +100.0% |
| Q1 2023 | $105,346 | -2.3% | 15,794 | +13.0% | 0.00% | 0.0% |
| Q4 2022 | $107,778 | -24.1% | 13,979 | +4.7% | 0.00% | 0.0% |
| Q3 2022 | $142,000 | +34.0% | 13,357 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $106,000 | +37.7% | 12,969 | +20.3% | 0.00% | 0.0% |
| Q1 2022 | $77,000 | -57.9% | 10,781 | +0.8% | 0.00% | 0.0% |
| Q4 2021 | $183,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $26,790,000 | 44.35% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $50,694,446,000 | 9.21% |
| Samsara BioCapital, LLC | 775,583 | $28,309,000 | 3.50% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $55,088,000 | 3.17% |
| Laurion Capital Management LP | 3,858,617 | $140,839,000 | 0.78% |
| Casdin Capital, LLC | 548,156 | $20,008,000 | 0.51% |
| ALLEN OPERATIONS LLC | 68,104 | $2,486,000 | 0.43% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 472,552 | $17,248,000 | 0.40% |
| Ratan Capital Management LP | 110,000 | $4,015,000 | 0.35% |
| Comprehensive Financial Management LLC | 1,109,395 | $40,493,000 | 0.34% |